HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong-Jin Hwang Selected Research

Therapeutics

11/2023Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype.
2/2021An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer.
1/2019Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.
1/2019Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.
1/2018A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
11/2017Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.
8/2010Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong-Jin Hwang Research Topics

Disease

11Neoplasms (Cancer)
11/2023 - 07/2012
11Prostatic Neoplasms (Prostate Cancer)
01/2023 - 07/2012
2Melanoma (Melanoma, Malignant)
01/2019 - 09/2015
1Triple Negative Breast Neoplasms
11/2023
1Insulin Resistance
01/2018
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Necrosis
11/2016
1Muscular Atrophy (Muscle Atrophy)
08/2010
1Muscular Diseases (Myopathy)
08/2010
1Osteoporosis
08/2010
1Hypogonadism (Hypergonadotropic Hypogonadism)
08/2010
1Atrophy
08/2010

Drug/Important Bio-Agent (IBA)

7Androgen Receptors (Androgen Receptor)IBA
11/2023 - 08/2010
5enzalutamideIBA
01/2023 - 01/2019
5Tubulin ModulatorsIBA
01/2019 - 07/2012
2AndrogensIBA
11/2023 - 08/2010
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2018
1InterferonsIBA
11/2023
1Janus Kinase InhibitorsIBA
11/2023
1Janus KinasesIBA
11/2023
1Cysteine (L-Cysteine)FDA Link
01/2023
1Androgen Antagonists (Antiandrogens)IBA
01/2023
1Androgen Receptor AntagonistsIBA
01/2023
1Diethylstilbestrol (Stilbestrol)FDA Link
02/2021
1Estrogens (Estrogen)FDA Link
02/2021
1LigandsIBA
11/2019
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2019
1pyridineIBA
01/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Protein Isoforms (Isoforms)IBA
11/2017
1TubulinIBA
09/2015
1Antineoplastic Agents (Antineoplastics)IBA
07/2012
1(3- (1H- indol- 2- yl)phenyl)(1H- indol- 2- yl)methanoneIBA
07/2012
1indoleIBA
07/2012
1Proteins (Proteins, Gene)FDA Link
08/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
08/2010
1GlucocorticoidsIBA
08/2010
1Ligases (Synthetase)IBA
08/2010
1Phosphotransferases (Kinase)IBA
08/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2010
1Testosterone (Sustanon)FDA Link
08/2010
1UbiquitinIBA
08/2010

Therapy/Procedure

7Therapeutics
11/2023 - 08/2010
4Castration
02/2021 - 08/2010